FDA OKs anti-itch treatment Hydrocortisone-D from Apricus

08/23/2011 | San Diego Union-Tribune

Apricus Biosciences' Hydrocortisone-D, an anti-itch medicine, was approved by the FDA. The reformulated over-the-counter drug features Apricus' NexACT molecules, boosting drug absorption through the skin. Last week, the drugmaker gained regulatory approval for anti-fungal treatment Tolnaftate-D.

View Full Article in:

San Diego Union-Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN